KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Cost of Revenue (2016 - 2025)

Quest Diagnostics' Cost of Revenue history spans 17 years, with the latest figure at $1.9 billion for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 7.54% year-over-year to $1.9 billion; the TTM value through Dec 2025 reached $7.4 billion, up 11.19%, while the annual FY2025 figure was $7.4 billion, 11.19% up from the prior year.
  • Cost of Revenue for Q4 2025 was $1.9 billion at Quest Diagnostics, up from $1.9 billion in the prior quarter.
  • Across five years, Cost of Revenue topped out at $1.9 billion in Q4 2025 and bottomed at $1.5 billion in Q3 2023.
  • The 5-year median for Cost of Revenue is $1.6 billion (2021), against an average of $1.7 billion.
  • The largest annual shift saw Cost of Revenue grew 28.17% in 2021 before it dropped 8.32% in 2022.
  • A 5-year view of Cost of Revenue shows it stood at $1.7 billion in 2021, then fell by 8.32% to $1.6 billion in 2022, then dropped by 1.46% to $1.6 billion in 2023, then grew by 13.6% to $1.8 billion in 2024, then grew by 7.54% to $1.9 billion in 2025.
  • Per Business Quant, the three most recent readings for DGX's Cost of Revenue are $1.9 billion (Q4 2025), $1.9 billion (Q3 2025), and $1.8 billion (Q2 2025).